Virtual Library
Start Your Search
T. Yokota
Author of
-
+
P3.16 - Surgery (ID 732)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Surgery
- Presentations: 1
- Moderators:
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.16-022 - Surgery for Non-Small-Cell Lung Cancer with Malignant Minor Pleural Effusion Detected on Thoracotomy (ID 8970)
09:30 - 09:30 | Presenting Author(s): T. Yokota
- Abstract
Background:
Surgery is usually not indicated for malignant pleural effusion due to its poor prognosis. However, malignant pleural effusion is first detected at thoracotomy　(malignant minor pleural effusion), and it is difficult to judge an appropriate mode of resection. Several reports have demonstrated that the prognosis of patients with malignant pleural effusion first detected at thoracotomy is relatively favorable, aggressive surgical approaches may result in long-term survival. In some cases long-term survival is expected for malignant pleural disease unless the causal tumor is highly responsive to systemic chemotherapy. The aim of this study is to describe the results of surgical intervention in NSCLC patients with malignant minor pleural effusion.
Method:
We retrospectively studied 21 surgical patients with NSCLC and malignant minor pleural effusion that is found during thoracotomy, from January 1989 till March 2017. Surgical-pathological staging was carried out according the 7th edition of the TNM classification of lung cancer. We examined the clinicopathological features, the current status of therapy, and surgical outcomes in patients with malignant minor pleural effusion.
Result:
The median survival time and 5-year survival rate in the 21 patients were 16.9 months and 19.3%. Primary tumor resection was perfomed in 20 patinets(95.2%), pneumonectomy was 1 case, lobectomy was 14 cases, segmetectomy was 1 case and wedge resection was 4 cases. Of our 21 petients, 10 had malignant pleural nodule. The 5-year survival rate for 10 patients with malignant pleural nodule was 0%, whereas the 5-year survival rate for 11 patients without malignant pleural nodule was 30.0%. But there is no significant difference in survival between with or without malignant pleural nodule. Univariate analyses revealed that women, adenocarcinoma histology were associated with significant longer survival. 6 patients(28.6%) survive more than 3 years and 3 patients(14.3%) survive more than 5 years, all patients were adenocarcinoma, cN0.
Conclusion:
Tumor resection is beneficial for the survival of several patients with NSCLC who have a minor malignant pleural effusion. Our results warrant to the possible benefits of surgery in NSCLC patients, and to justify the inclusion of surgery in multimodality treatment of NSCLC patients with minor malignant pleural effusion.
